Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy

Wednesday, May 22, 2019 1 min read

Key Takeaway: Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy

Full Press Release Details

Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy.